Amedica (AMDA) Misses Q3 EPS by 9c

Amedica (NASDAQ: AMDA) reported Q3 EPS of ($0.15), $0.09 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $4.8 million versus the consensus estimate of $5 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c